HUMANA INC ($NYSE:HUM) reported their financial results for the Second Quarter of FY2023 ending June 30 2023 on August 2 2023. Total revenue reached USD 26747.0 million, indicating a 13.0% growth compared to the same period of the previous year. Net income rose to USD 959.0 million, representing a 37.8% year-over-year increase.
At market open, the company’s stock opened at $484.1 and closed at $483.8, up 5.6% from the prior closing price of $458.1. Humana Inc. attributed its strong results to an increase in membership due to their acquisition of various health care providers over the past two years. They also credited increased demand for their products and services from consumers due to the pandemic.
Additionally, Humana Inc. reported that they had implemented numerous cost-saving measures which further contributed to their positive performance in the quarter. Overall, the strong performance of Humana Inc. in the second quarter of FY2023 has set a positive tone for the rest of the year and investors have responded positively to the news. With continued focus on cost-savings, expansion of their business and increase in consumer demand, Humana Inc. is well positioned for success in the future. Live Quote…
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Humana Inc. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Humana Inc. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Humana Inc. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Humana Inc are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Analysis – Humana Inc Stock Fair Value Calculator
GoodWhale has conducted an in-depth analysis of HUMANA INC‘s financials. Our proprietary Valuation Line reveals that the intrinsic value of HUMANA INC share is around $530.1. However, the stock is currently traded at $483.8, which is a fair price though undervalued by 8.7%. This presents an opportunity for investors to buy the stock at a discounted price. More…
Risk Rating Analysis
Star Chart Analysis
In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.
– UnitedHealth Group Inc ($NYSE:UNH)
UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.
UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.
The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.
Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.
– Oscar Health Inc ($NYSE:OSCR)
Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.
Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.
Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.
Investors in Humana Inc were pleased to see the strong second quarter results for FY2023, announced on August 2 2023. Revenue of USD 26747.0 million represented a 13.0% year-over-year increase, whilst net income rose 37.8%.The stock price moved up on the same day, and the overall financial performance contributes to a positive outlook for the company going forward. Analysts will be monitoring the developments at Humana Inc closely, as the strong revenue and income figures indicate a healthy financial position in the near-term.